STRATASYS LTD. annual report, Q4 FY2023

Stratasys Ltd. — FY2023 Form 20-F

Reporting period: Fiscal year ended December 31, 2023. This is an annual report, not a standalone Q4 earnings release; the filing does not provide a clear set of Q4-only financial results in the supplied text. Figures below are U.S. dollars unless stated otherwise.

Business context

Stratasys is an Israeli-incorporated, Nasdaq-listed provider of polymer-based 3D printing systems, consumables, software and services, including on-demand parts production. It reports one operating segment. Its strategy centers on a broad portfolio of polymer technologies and expanding manufacturing applications. The April 2023 Covestro additive-manufacturing materials acquisition broadened its materials portfolio.

Key financial metrics

MetricFY2023FY2022
Revenue$627.6 million$651.5 million
Gross profit / margin$267.0 million / 42.5%$276.5 million / 42.4%
Operating loss / margin$87.6 million / (14.0%)$57.2 million / (8.8%)
Net loss$123.1 million$29.0 million
Diluted loss per share$1.79$0.44
Operating cash flow$(61.6) million$(75.4) million
Capital expenditures$15.0 million$19.8 million

Product revenue declined 4.1% to $433.7 million; services revenue declined 2.8% to $193.9 million. Systems revenue fell 16.5%, while consumables revenue rose 8.2%, supported by higher utilization of the installed base and acquired businesses. Americas revenue fell 6.2%; EMEA rose 10.1%; Asia Pacific fell 13.3%.

Gross margin was broadly stable: product margin was 47.8% versus 48.1%, and services margin improved to 30.8% from 29.6%. Operating expenses increased 6.3% to $354.6 million, including $32.9 million of costs associated with potential transactions, defense against Nano Dimension’s tender offer and board contest, and related professional fees. The 2022 comparison included a $39.1 million gain from deconsolidating MakerBot, which did not recur.

Management’s non-GAAP reconciliation reported 2023 operating income of $12.6 million and net income of $7.7 million, versus $13.5 million and $10.3 million, respectively, in 2022. These measures exclude specified items, including acquisition-related amortization, stock compensation, restructuring, legal costs and other adjustments; they supplement, not replace, GAAP results.

Liquidity, debt and balance sheet

At year-end, cash and cash equivalents were $82.6 million, short-term deposits were $80.0 million, and restricted cash was $0.3 million. Cash, cash equivalents and short-term deposits totaled approximately $162.6 million, down about $165.3 million from 2022. Current assets were $560.1 million and current liabilities were $176.4 million. Total liabilities were $249.1 million; management stated that the company had no debt.

Cash used in investing activities was $3.8 million, including $72.1 million for business combinations and $13.6 million for property and equipment, largely offset by net proceeds from short-term deposits. The company had $140.8 million of ordinary-course supplier purchase obligations due during 2024 and potential acquisition-related contingent payments of up to $104.4 million. These contingent payments depend on future events and may not become payable.

Material developments, outlook and risks

  • Strategic transactions: Shareholders rejected the Desktop Metal merger in September 2023; Stratasys terminated the agreement and paid a $10.0 million termination fee. The board began a comprehensive strategic-alternatives review. 3D Systems’ proposals were rejected after the board concluded the revised offer undervalued the company.
  • Nano Dimension: Nano’s 2023 tender offer expired without purchasing shares, and its nominees were not elected. In December 2023, Nano proposed to buy shares it did not own for $16.50 per share. Litigation over Stratasys’ shareholder rights plan remained pending; the filing describes a preliminary court view, not a final ruling.
  • 2024 outlook: Management expected revenue to grow sequentially, largely on anticipated later-year product introductions. The supplied filing text does not provide a clear numerical full-year 2024 revenue or earnings forecast. Management cautioned that macroeconomic uncertainty makes guidance less certain.
  • Management commentary: Higher interest rates and customer capital-spending pressure lengthened system sales cycles and led to occasional order deferrals. Management cited cost controls, cash generation and planned product investment, and expects margin improvement if inflationary pressures ease and product mix develops favorably.
  • Unusual items and investments: Stratasys recorded $19.2 million of restructuring-related charges in 2023; restructuring was substantially complete by year-end. It also recorded a $13.9 million impairment of its Ultimaker equity investment, which stood at $67.8 million at year-end. No goodwill impairment was recorded; the Stratasys-Core reporting unit’s estimated fair value exceeded carrying amount by about 34%.
  • Principal risks: Persistent macroeconomic weakness, inflation and financing conditions; competition and product-mix pressure; execution and impairment risks from acquisitions; foreign-exchange exposure; reliance on sole-source PolyJet print heads from Ricoh; Israel’s war and regional instability; and the unresolved rights-plan litigation. Management said the war’s effect on 2023 results was limited and Israeli operations remained largely unaffected as of the filing, but warned the impact could grow.

Investor facts to verify

  • Track whether system sales cycles recover and consumables growth continues to offset weaker systems revenue.
  • Review cash burn, working-capital movements and the timing of the $140.8 million supplier commitments and contingent acquisition payments.
  • Follow the strategic-alternatives process, Nano’s $16.50 proposal and the Israeli court proceedings concerning the rights plan.
  • Assess whether Ultimaker’s restructuring improves performance and whether further impairment or goodwill charges emerge.
  • Compare any later 2024 guidance and product-launch results with management’s stated expectation of sequential revenue growth.
  • Note that the auditor issued an unqualified opinion on the financial statements and found internal control over financial reporting effective; audit critical matters included goodwill valuation, Covestro purchase-price allocation and the Ultimaker impairment assessment.